Cleerly Stock

cleerlyhealth.comHealthcare / Digital HealthFounded: 2016Funding to Date: $286.4MM

Cleerly, founded in 2016, is a digital healthcare company using AI to create a new standard of care for heart disease. The Cleerly platform is aiming to differentiate itself by using AI to measure plaque build-up in the heart’s arteries versus using indirect markers, like risk factors and symptoms of disease to help clinicians identify and define heart disease earlier and provide personalized treatment plans to patients.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Cleerly, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Cleerly’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Cleerly.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Cleerly investors also invested in these private companies

Team

Management Team

James Min MD
Founder, Chief Executive Officer, President & Board Member
Krissy Wright
Chief Financial Officer
Joseph Jasser MD
Chief Operating Officer
Kimberly McCombs
Chief Strategy Officer
Nick Nieslanik
Chief Technology Officer
Zach Hong
Chief Compliance Officer & General Counsel
Jim Hartman
Chief Revenue Officer
Udo Hoffmann MD
Chief Scientfic Officer
James Earls MD
Chief Medical Officer
Kristin Binns
Chief Marketing & Communications Officer

Board Members

Glenn Steele Ph.D
LRVHealth
Justin Klein MD
Vensana Capital
Tripp Peake III
LRVHealth
Vijay Lathi
New Leaf Venture

Cleerly stock FAQs

plusminus

Can you buy Cleerly stock?

As Cleerly is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Cleerly, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Cleerly stock?

To invest in a private company like Cleerly through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Cleerly stock?

Yes, you may be able to sell your Cleerly stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Cleerly stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Cleerly stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Cleerly a public company?

No, Cleerly is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Cleerly’s stock price?

Cleerly is a privately held company and therefore does not have a public stock price. However, you may access Cleerly’s private market stock price with Forge Data.
plusminus

What is Cleerly’s stock ticker symbol?

Cleerly does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Digital healthcare company Cleerly is leveraging AI technology to revolutionize the diagnosis of heart disease. Their platform uses imaging and AI to detect atherosclerosis at an early stage, enabling more personalized and effective treatment plans. The company is also sponsoring a trial, TRANSFORM, to validate the efficacy of this personalized care strategy.
Cardiologist James Min, former professor at Weill Cornell Medical College and director of the Dalio Institute of Cardiovascular Imaging at New York-Presbyterian, founded Cleerly to find a better way to assess heart health, by applying AI to the problem, cutting down on the time it takes to flag issues and ultimately reach his goal of a “heart-attack free” world.
Cleerly, a New York-based health tech startup, has raised $192 million in a funding round led by investment firms T. Rowe Price (TROW.O) and Fidelity Management & Research Company LLC.
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.